{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:13:53Z","timestamp":1793160833491,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2887,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.fertnstert.2014.03.054","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T11:31:07Z","timestamp":1398771067000},"page":"116-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Long-term influence of combined oral contraceptive use on the clinical course of relapsing\u2013remitting multiple sclerosis"],"prefix":"10.1016","volume":"102","author":[{"given":"Giulia","family":"Gava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Venturoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Meriggiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.03.054_bib1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2009.04.014","article-title":"Sex hormones, brain damage and clinical course of multiple sclerosis","volume":"286","author":"Tomassini","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","article-title":"Temporal trends in the incidence of multiple sclerosis: a systematic review","volume":"71","author":"Alonso","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/brain\/awh714","article-title":"Age at disability milestones in multiple sclerosis","volume":"129","author":"Confavreux","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"Vukusic","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/jnnp.2008.163816","article-title":"Long-term effects of childbirth in MS","volume":"81","author":"D'hooghe","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00415-011-6267-7","article-title":"Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset of multiple sclerosis","volume":"259","author":"D'hooghe","year":"2012","journal-title":"J Neurol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.10301","article-title":"Treatment of multiple sclerosis with the pregnancy hormone estriol","volume":"52","author":"Sicotte","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2009.05.028","article-title":"Estrogen treatment in multiple sclerosis","volume":"286","author":"Gold","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib11","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1210\/en.2011-1219","article-title":"Progesterone and nestorone facilitate axon remyelination: a role for progesterone receptors","volume":"152","author":"Hussain","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brainres.2009.04.057","article-title":"Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis","volume":"1283","author":"Garay","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2009.04.038","article-title":"Oral contraceptives and the risk of multiple sclerosis: a review of the epidemiologic evidence","volume":"286","author":"Alonso","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0010-7824(93)90088-O","article-title":"Oral contraceptives and reproductive factors in multiple sclerosis incidence","volume":"47","author":"Villard-Mackintosh","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib15","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1471-0528.1998.tb10008.x","article-title":"The influence of oral contraceptives on the risk of multiple sclerosis","volume":"105","author":"Thorogood","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/WNL.55.6.848","article-title":"Oral contraceptives and the incidence of multiple sclerosis","volume":"55","author":"Hern\u00e0n","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/archneur.62.9.1362","article-title":"Recent use of oral contraceptives and the risk of multiple sclerosis","volume":"62","author":"Alonso","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib18","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.fertnstert.2010.06.045","article-title":"Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis","volume":"94","author":"Holmqvist","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2012.02.033","article-title":"Oral contraceptive use and clinical outcomes in patients with multiple sclerosis","volume":"317","author":"Sena","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib22","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jns.2008.11.020","article-title":"The multiple sclerosis severity score (MSSS) predicts disease severity over time","volume":"278","author":"Pachner","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib25","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.166.3.2080","article-title":"Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains","volume":"166","author":"Bebo","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.170.3.1548","article-title":"Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system","volume":"170","author":"Subramanian","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2826.2012.02284.x","article-title":"Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis","volume":"24","author":"Giatti","year":"2012","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0010-7824(97)00070-X","article-title":"A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity","volume":"56","author":"Rossmanith","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib29","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"PRISMS (Prevention of Relapses and Disability by Interferon Beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(03)12512-3","article-title":"Interferons in relapsing remitting multiple sclerosis: a systematic review","volume":"361","author":"Filippini","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jama.2012.7625","article-title":"Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis","volume":"308","author":"Shirani","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2014.03.054_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.20330","article-title":"Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis","volume":"78","author":"Offner","year":"2004","journal-title":"J Neurosci Res"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214003094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214003094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:09:55Z","timestamp":1758010195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214003094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0015028214003094"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.054","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term influence of combined oral contraceptive use on the clinical course of relapsing\u2013remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}